The study, published in BMC Plastic and Reconstructive Surgery, set out to answer a deceptively simple question: how large is the gap that forms the instant a healthy nerve is cut, before any swelling, scarring, or retraction of tissue can complicate the picture? The answer, measured across forty-four rat sciatic nerves, was an average of 4.0 millimeters, with individual gaps ranging from 2 to 6 millimeters and a standard deviation of 1.10 millimeters. Because the average diameter of the nerves at the transection site was 2.0 millimeters, the researchers concluded that the immediate gap is roughly twice the width of the nerve itself.

That ratio matters because the gap is produced purely by elastic recoil, the inherent springiness of nerve tissue, and not by any pathological process. The authors argue that this so-called time zero gap should be recognized as a normal finding rather than a defect that automatically demands a nerve graft. In an era when processed nerve allografts have become increasingly popular, and when some surgeons advocate grafting even freshly lacerated nerves to avoid any tension at the repair site, the distinction is clinically significant. Primary end-to-end repair has consistently produced better outcomes than any interposition graft, whether autograft or allograft, so the threshold for abandoning direct repair carries real consequences for patients.

The experimental design was deliberately minimalist. Twenty-two live male Sprague-Dawley rats, each weighing approximately 300 grams, were anesthetized with intraperitoneal ketamine and xylazine. All procedures were approved by the Columbia University Medical Center Institutional Animal Care and Use Committee, and a single surgeon performed every dissection under an operating microscope to eliminate variability between operators. The animals were positioned prone with their limbs secured close to the midline in a relaxed posture, a detail chosen specifically to minimize background tension on the sciatic nerve so that any gap measured afterward could be attributed to the nerve’s own elasticity rather than to body positioning.

Through blunt dissection at the plane between the quadriceps femoris and biceps femoris muscles, the surgeon exposed one centimeter of each sciatic nerve and carefully freed it from surrounding tissue without damaging its vessels or branches. The diameter of the nerve at the planned transection site was recorded with a ruler before a fresh scalpel blade divided the nerve at its midpoint, with a wooden spatula placed beneath it to shield underlying structures. After the spatula was withdrawn, the researchers took extreme care not to manipulate the nerve ends, then measured the distance between them. The primary outcome measure was simply that distance, captured at the moment of creation.

The statistical picture that emerged was strikingly consistent. Beyond the mean gap of 4.0 millimeters, the distribution of measured gaps clustered tightly around that value. Nerve diameters averaged 2.0 millimeters with a range of 1.0 to 2.0 millimeters and a standard deviation of 0.30 millimeters. Perhaps most interesting was what the correlation analysis did not show: the Pearson correlation coefficient between gap size and nerve diameter was just 0.093, a very weak positive relationship. In other words, thicker nerves did not reliably produce proportionally larger gaps in this sample, suggesting that the recoil behavior is governed by factors beyond simple geometry, possibly including the composition of the connective tissue within and around each nerve.

The clinical context for these numbers is a long-running debate over tension at nerve repair sites. Basic science has shown that acute stretching of a nerve compromises its blood flow and can impair regeneration, which is the physiological rationale for keeping repairs tension-free. Yet the same literature demonstrates that nerves can tolerate substantial gradual elongation, as limb and finger lengthening procedures prove. Work by Mackinnon and colleagues in a rat sciatic model showed that acute elongation to bridge a gap can be problematic, but that modest dissection to free up the nerve markedly reduces tension at the repair site. Surgeons also exploit a property called stress-relaxation: placing a few larger-caliber sutures to hold the nerve ends together and waiting a few minutes allows the tissue to stretch out, after which fine sutures can complete the repair under far less load.

Historical evidence leans further in favor of direct repair. In one of the few primate studies on the question, Hentz and colleagues repaired the ulnar nerves of Cynomolgus monkeys either end-to-end under tension or with interposition autografts under no tension, and the nerves repaired primarily under tension fared better. They concluded that for defects of up to three to four centimeters in adult humans, modest tension across a repair site is superior to achieving a tension-free repair with a graft. Against that backdrop, the new measurement of the time zero gap serves as a reminder that a visible gap immediately after injury is not evidence that the nerve is missing tissue; it is evidence that elastic tissue has sprung apart.

The authors offer a practical extrapolation. A human median nerve at the wrist has a diameter of roughly five millimeters, so if the two-to-one ratio holds, a fresh transection there would produce an instantaneous gap of about one centimeter. The team notes that they have clinically observed gaps exceeding one centimeter in acutely lacerated median and ulnar nerves, which is consistent with the rat data. Such a gap, seen in the emergency room or the operating theater within hours of injury, can look alarming and may prompt a decision toward allograft reconstruction. The study’s message is that this gap is usually recoverable through mobilization, joint positioning, and stress-relaxation techniques, and that a recent study by Jain and colleagues found nerve recoil did not appear to worsen over time, even as the window for primary repair of major nerves may be as short as two days.

The researchers are candid about the limitations of their work. They measured a single time point, so dynamic changes after injury, such as progressive retraction or early tissue remodeling, were not captured. The rat sciatic nerve, while a workhorse model in peripheral nerve research, differs from human nerves in diameter, connective tissue composition, and surrounding anatomy, all of which could influence how gaps develop in patients. The use of an analog rather than a digital ruler also leaves room for greater precision in future studies. The authors suggest that ethically feasible human data could be gathered during intentional neurotomies performed for denervation, nerve transfer, or neuroma treatment, procedures in which gaps form under controlled conditions. For now, the study establishes a baseline that has never existed before: cut a rat sciatic nerve and it will spring apart by twice its own width, a gap that primary repair can readily overcome and that, by itself, is no reason to reach for a graft.

Subject of Research: Quantification of the acute nerve gap produced by elastic recoil after rat sciatic nerve transection

Article Title: Time zero nerve gap created by rat sciatic nerve transection

Article References: Shukhmakher, E., Akelina, Y., & Strauch, R. J. (2025). Time zero nerve gap created by rat sciatic nerve transection. BMC Plastic and Reconstructive Surgery, 1(1), Article 5. https://doi.org/10.1186/s44452-025-00005-5

Image Credits: AI Generated

DOI: 10.1186/s44452-025-00005-5

Keywords: peripheral nerve injury, sciatic nerve, nerve transection, elastic recoil, nerve gap, nerve grafting, nerve allograft, primary nerve repair, microsurgery, rat model, nerve regeneration, tension at repair site

The biology underlying peripheral nerve repair is intricate. After a nerve is transected, the segment downstream of the cut undergoes Wallerian degeneration, a process in which the axoplasm and axolemma break down and myelin debris accumulates in the injured stump. This debris must be cleared before new axons can grow. Schwann cells, the glial cells of the peripheral nervous system, respond by rapidly de-differentiating into repair-mode cells that secrete pro-regenerative factors, digest myelin through autophagy, recruit macrophages, and form regeneration tracks, known as bands of Büngner, that guide growing axons from the proximal stump back toward their original targets. Macrophages, meanwhile, perform the dual tasks of removing debris and supporting axon elongation. Coordinating all of these players takes time; axons may need up to ten months to reach their target tissues, which is why clinicians have long sought drugs that can safely speed the process.

Neurotrophic factors, the signaling proteins that nurture neuronal survival and growth, have been an obvious place to look. Molecules such as nerve growth factor, brain-derived neurotrophic factor, glial cell line-derived neurotrophic factor, VEGF and IGF-1 have all shown promise in experimental settings. Yet their clinical translation has been hampered by poor pharmacokinetics, high costs and significant side effects. Basic fibroblast growth factor, or bFGF, is one of the most powerful of these agents, secreted by Schwann cells and neuronal populations, and it stimulates the proliferation of neurons, Schwann cells and fibroblasts while playing a pivotal role in nerve and spinal cord repair. But native bFGF has a troubled clinical record. A trial in acute stroke patients failed to demonstrate efficacy and revealed fever, lowered blood pressure, elevated leukocyte counts and potential carcinogenic effects, largely because the growth factor also drives cell proliferation.

SUN11602 was designed to sidestep that problem. It is a small aniline-derivative molecule that mimics the neuroprotective effects of bFGF by engaging the same receptor, FGFR1, a transmembrane tyrosine kinase receptor to which bFGF binds with high affinity. Crucially, SUN11602 activates FGFR1 to induce expression of calbindin-D28k, a calcium-binding protein that helps maintain intracellular calcium homeostasis, without triggering the proliferative activity that makes native bFGF risky. The compound also boasts pharmacokinetics that make it a plausible drug candidate: oral bioavailability above 65 percent in rodents and dogs. Previous studies have suggested neuroprotective effects in models of Alzheimer’s disease, depression, Parkinson’s disease and traumatic spinal cord injury, but its role in peripheral nerve regeneration had not been tested.

To fill that gap, the Messina team used sixteen female Wistar rats and a surgically precise injury model. Under an operative microscope, the median nerve of the left upper limb was exposed at the middle third of the brachium and transected, then repaired with an end-to-end suture using two to three epineurial stitches of 9-0 monofilament nylon, replicating the standard clinical repair technique. Beginning 24 hours after surgery, one group of injured rats received SUN11602 at 2.5 milligrams per kilogram by oral gavage once daily for seven consecutive days, while injured controls received only saline. A sham group underwent incision without nerve section. The dose and route were grounded in earlier in vivo work by the same laboratory, and the study was conducted under Italian and European animal research regulations with approval from the Ministry of Health.

Seven days after suture, the differences between groups were visible under the microscope. Haematoxylin and eosin staining revealed that the injured, untreated nerves had the expected hallmarks of acute Wallerian degeneration: structural disorganization, oedema, vacuolization and early myelin and axonal degeneration. Nerves from the SUN11602-treated animals, by contrast, showed comparatively preserved architecture, with reduced vacuolization and less tissue disarray. In other words, the drug appeared to blunt the secondary damage that typically accompanies the degenerative phase, without abolishing degeneration itself, which the authors emphasize is a physiologically required step for successful regeneration.

The anti-inflammatory effects were equally striking. Toluidine blue staining, which highlights mast cells, showed that injured control nerves accumulated large numbers of these cells in the connective tissue and along axon fibres with irregular morphology and degenerating myelin sheaths. Mast cells congregate near peripheral nerves and are considered key orchestrators of neurogenic inflammation and neuropathic pain. In the SUN11602-treated group, mast cell accumulation was suppressed and axon fibre density was higher. Immunostaining for IBA-1, a marker of activated resident macrophages, and CD68, a marker of pro-inflammatory M1 macrophages that infiltrate the injury site and release cytokines, both showed intense upregulation after nerve transection. SUN11602 treatment significantly attenuated both, suggesting the drug restrains the inflammatory response that can otherwise impede repair in the critical first days after injury.

The compound also appeared to support the rebuilding side of the ledger. Immunofluorescence labeling for S100, a Schwann cell marker, showed more consistent and interconnected stained areas in treated nerves, indicating enhanced Schwann cell proliferation and myelinization. Quantification of myelin basic protein by ELISA confirmed the histological picture: concentrations of MBP were significantly higher in the SUN11602 group than in injured controls, evidence of increased myelin production at the molecular level. MCOLL staining, a histochemical method that distinguishes myelin in blue from collagen fibers in red, allowed the researchers to visualize the nodes of Ranvier and the organization of connective tissue around nerve fibers. Injured control nerves showed marked demyelination and disorganized collagen deposition consistent with fibrosis, whereas treated nerves displayed axonal remyelination and reorganized collagen architecture.

The authors are careful about what these findings do and do not mean. All evaluations were performed at a single early time point, seven days after suture, when axonal regeneration and remyelination are only beginning. The observed attenuation of myelin degradation, they write, should not be read as a global inhibition of Wallerian degeneration; rather, they hypothesize that SUN11602 may selectively reduce secondary or excessive demyelination in spared fibers, a distinction that will require ultrastructural analysis and time-course studies of myelin clearance to confirm. The histological improvements also remain unlinked to functional recovery, since no electrophysiological or behavioral testing was included. Future work, the team notes, should incorporate extended follow-up periods, functional and electrophysiological assessments, and combination strategies such as nerve conduits and biomaterials to better mimic complex clinical conditions.

Even with those caveats, the study adds SUN11602 to a short list of candidates that could reshape how peripheral nerve injuries are treated. Because it is orally bioavailable and lacks the proliferative liabilities of native bFGF, the compound addresses the two biggest obstacles that have kept neurotrophic therapies out of the clinic: delivery and safety. If the early histological benefits observed here translate into sustained axonal regrowth, remyelination and functional recovery in longer studies, an oral pill taken in the days and weeks after nerve repair surgery could become a genuine adjunct to the operating microscope. For now, the message from Messina is a proof of principle: the molecular machinery of nerve regeneration can be pharmacologically tuned, and the earliest, most inflammatory phase of repair may be the best place to intervene.

Subject of Research: Pharmacological enhancement of early peripheral nerve regeneration using the oral FGFR1 agonist SUN11602 in a rat median nerve transection model

Article Title: SUN11602 Accelerates Early Peripheral Nerve Regeneration in an Experimental Median Nerve Transection Model

Article References: Casili, G., Papalia, I., Ardizzone, A., Basilotta, R., Costa, A. L., Titolo, P., Esposito, E., Colonna, M. R., & Galeano, M. (2026). SUN 11602 Accelerates Early Peripheral Nerve Regeneration in an Experimental Median Nerve Transection Model. Journal of Cellular and Molecular Medicine, 30(19), Article e71375. https://doi.org/10.1111/jcmm.71375

Image Credits: AI Generated

DOI: 10.1111/jcmm.71375

Keywords: peripheral nerve injury, SUN11602, FGFR1, bFGF, Schwann cells, Wallerian degeneration, mast cells, macrophages, myelination, median nerve transection, neuroprotection, rat model

The study, published in BMC Neuroscience by Yujie Chen, Xinyi Gu, Sirui Tang, Huiran Zang and Guangxue Li of Peking University People’s Hospital and collaborators, set out to answer a deceptively simple question: when an RPNI is built on the end of a transected nerve, how does the rest of the nervous system respond? The technique works by wrapping the cut end of a nerve in a small, free graft of muscle. The denervated muscle fibers within the graft become reinnervated by the regenerating axons, effectively creating a living biological target that absorbs the sprouting nerves and, in principle, prevents the chaotic growth that drives neuroma pain.

What makes the new work unusual is its ambition to look beyond the surgical site. Most studies of nerve interfaces focus on the local environment of the graft, examining how well axons regenerate and how the muscle responds. The Chinese team instead performed RNA sequencing on four tissues from each animal: the reconstructed nerve itself, the dorsal root ganglion where the sensory neuron cell bodies live, the thalamus, and the hippocampus. The thalamus serves as a critical relay station for sensory signals on their way to the cortex, while the hippocampus, though best known for memory, is increasingly recognized as a site where chronic pain leaves measurable traces. By sampling all four tissues simultaneously, the researchers hoped to catch echoes of the peripheral reconstruction propagating into the central nervous system.

The experimental design was rigorous for an exploratory study of this size. Thirteen male rats were randomized into three groups. Three animals received a sham procedure, five underwent sciatic nerve transection with no reconstruction, leaving an untreated nerve stump, and five received sciatic nerve transection followed by RPNI reconstruction. Eight weeks after surgery, the team harvested the four tissues from every animal, generating fifty-two RNA sequencing libraries in total. The researchers used DESeq2, a standard statistical framework for differential expression analysis, across all fifty-two libraries, and then repeated key analyses on an overlapping thirty-six-library subset as a sensitivity check to make sure their results were not artifacts of one particular statistical choice.

The molecular results were strikingly tissue-specific. Comparing RPNI animals directly with unreconstructed stump animals, the team found 189 differentially expressed genes in the nerve itself, sixty-seven in the dorsal root ganglion, only two in the thalamus, and a mere six in the hippocampus, all using a false discovery rate threshold of five percent and a minimum absolute log2 fold change of one. In other words, the further upstream one travels from the site of reconstruction, the quieter the transcriptional signal becomes. The nerve and its associated sensory neurons show a robust molecular response to the presence of the regenerative interface, while the brain regions sampled show only faint traces of change at the gene expression level.

Yet the histology told a more nuanced story. When the researchers examined thalamic tissue under the microscope, they found that RPNI animals had significantly fewer Iba1-positive cell bodies, a marker of activated microglia, the resident immune cells of the brain that proliferate and change shape when neural injury or inflammation is present. They also counted fewer TUNEL-positive nuclei, an indicator of cell death, in the thalamus of reconstructed animals. Both differences reached statistical significance in Tukey-adjusted comparisons, with P values of 0.01602 and 0.01283 respectively. Standard hematoxylin and eosin and Nissl staining did not establish differences in overall cell counts. The microglial and cell-death findings suggest that, at the cellular level, reconstruction may be associated with a calmer central environment, even if that calm is not loudly reflected in the transcriptome of the thalamus.

Behaviorally, the picture was more ambiguous. The team scored autotomy, a behavior in which animals self-mutilate a denervated limb and a common proxy for neuropathic pain in rodent models, at four and eight weeks after surgery. Median autotomy scores were one in the RPNI group versus seven in the stump group at week four, and two versus nine at week eight. Those raw differences look dramatic, but with only five animals per group and Holm-adjusted P values of 0.1786 and 0.09524 across six comparisons, the differences did not reach conventional statistical significance. The authors are explicit that these results do not establish an analgesic effect of the procedure, even though the direction of the trend is consistent with what clinicians hope the technique can achieve.

Perhaps the most sobering findings came from the study’s cross-checks. When the researchers compared their RNA sequencing point estimates with quantitative reverse transcription PCR measurements for twenty-four candidate genes, the two methods gave estimates with opposite signs for twelve of them, half of the candidates tested. And when they searched for genes whose expression might be reversed by reconstruction across multiple tissues, they found no single gene shared across all tissues, and external comparisons against public rat nerve and mouse dorsal root ganglion datasets all yielded Benjamini-Hochberg adjusted q values of 0.30, far from significance. These results underscore how fragile exploratory signals can be when sample sizes are small and multiple tissues are interrogated at once.

The authors are admirably candid about the limits of their work. In their conclusions, they state that RPNI was associated with tissue-specific expression changes and selected thalamic histological differences, but that these exploratory findings do not establish global normalization, cross-tissue communication, or analgesic efficacy. That restraint matters in a field where enthusiasm for nerve interfaces sometimes outpaces the evidence. The study was funded by the Beijing Municipal Science and Technology Commission and the Peking University People’s Hospital Research and Development Funds, and it was approved by the institution’s animal ethics committee. The work was published open access on 28 September 2026 under a Creative Commons license.

For the growing community of surgeons and neuroscientists working on regenerative nerve interfaces, the study offers both a template and a caution. The template is the multi-tissue design itself: sampling peripheral nerve, sensory ganglia, and brain regions in the same animals provides a systems-level view that single-tissue studies cannot match. The caution is statistical: with five animals per group, only the largest effects survive correction, and the divergence between RNA sequencing and PCR measurements for half of the tested candidates shows how easily exploratory signals can mislead. Larger, adequately powered studies will be needed to determine whether the quieter thalamic microglia and the lower autotomy trends seen here mature into reliable evidence that RPNI reconstruction genuinely tames the central consequences of nerve injury. For now, the molecular echoes of reconstruction remain exactly what the authors call them: exploratory.

Subject of Research: Multi-tissue molecular and histological responses to regenerative peripheral nerve interface reconstruction after sciatic nerve transection in rats

Article Title: Exploratory multi-tissue profiling after regenerative peripheral nerve interface reconstruction in rats

Article References: Chen, Y., Gu, X., Tang, S., Zang, H., & Li, G. (2026). Exploratory multi-tissue profiling after regenerative peripheral nerve interface reconstruction in rats. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01055-w

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01055-w

Keywords: regenerative peripheral nerve interface, peripheral nerve injury, sciatic nerve transection, RNA sequencing, dorsal root ganglion, thalamus, microglia, neuropathic pain, autotomy, differential gene expression, neuroma prevention, rat model

The central obstacle has long been mechanical. Optical windows implanted through the skull have transformed neuroscience by letting researchers image the living brain over months, but those implants are stabilized by bone. Peripheral nerves have no such anchor. They are wrapped in soft, mobile muscle and connective tissue, and they stretch and shift with every step. Earlier attempts at chronic nerve windows relied on rigid frames that were prone to instability, misalignment, and tissue damage, and were easily dislodged by the animals’ grooming. The new approach solves the anchoring problem with a flexible implant cast from polydimethylsiloxane, or PDMS, a silicone elastomer whose elastic properties closely match those of soft tissue.

Surgeons split the biceps femoris muscle overlying the sciatic nerve, displace it with fine sutures, and slide the folded PDMS window into a subcutaneous pocket. Skin tension holds the implant’s outer brim in a circumferential groove, while regenerating fascia grows through holes in the subdermal brim to anchor the device long-term. The result is a fluid-filled optical port with an injection septum through which dyes can be delivered and debris can be cleared. The numbers are striking: the soft windows remained embedded for a median of about seven weeks, with 90 percent lasting at least 18 days and some exceeding 80 days. Rigid 3D-printed acrylic implants of comparable size, tested as a control, lasted a median of only about nine days.

Crucially, the implant does not appear to interfere with the nerve it exposes. Mice with windows walked without asymmetry on a grid-walking test, and muscle force and electromyography measurements of sciatic-innervated muscles three months after implantation showed no deficits, with compound muscle action potentials in the normal range. Histological sections of windowed nerves roughly 90 days after surgery revealed axon densities and calibers indistinguishable from the opposite, unoperated leg. The researchers report that fluorescent signals from the transgenic labels did not photobleach appreciably, allowing the same individual axons, identified by fiducial features such as bends and swellings, to be tracked repeatedly over at least 24 days.

The imaging itself combines multiple modalities. Confocal and two-photon microscopy captured fluorescently labeled axons and Schwann cells within roughly 30 to 100 micrometers of the nerve surface, while second-harmonic generation imaging revealed the collagen and elastin of the extracellular matrix without any label at all. Genetically encoded reporters did much of the heavy lifting: Thy1-YFP and Thy1-GCaMP mice label neurons, and S100-GFP mice label Schwann cells. A topical dye called Nile Red stains myelin sheaths and lipid droplets, and an injected tomato lectin conjugate outlines blood vessels, even allowing the team to film individual blood cells streaming through intraneural capillaries. Axon diameters measured through the window averaged about 4 micrometers, consistent with large myelinated fibers in the mouse sciatic nerve.

Then came the injuries, and the window delivered a front-row view. Within minutes of a partial crush injury, Schwann cells near the damage site swelled, retracted, and shifted position, while myelin and collagen outside the injury zone remained stationary. Within 20 to 30 minutes, the fluorescent signal from affected Schwann cells dropped sharply, and over the following hour the cells beaded up and pulled back their membranes, behavior consistent with conversion to the mobile repair phenotype that Schwann cells adopt to clear debris and guide regrowth. In axon-labeled mice, the distal portions of damaged fibers lost their fluorescence over one to two days as Wallerian degeneration set in, with visible fragmentation by day two.

Regeneration followed with cinematic clarity. By four days after injury, thin new axonal sprouts tipped with growth cones had emerged from the proximal nerve segments and pushed through the injury zone, often retracing the paths of the degenerated fibers. The researchers estimate regeneration rates of at least one millimeter per day, matching published values for the mouse sciatic nerve. Growth cones of this kind had previously been filmed only in zebrafish and in very superficial mouse nerves, never in a major mammalian nerve trunk. In compression injuries that preserved the endoneurial channels, the delicate collagenous tubes left behind by degenerated axons, regrowing fibers closely aligned with those residual channels, supporting the long-standing idea that the extracellular matrix provides physical guidance cues for pathfinding. In one striking case, an axon encountering a surgically deformed channel deviated from it and sprouted multiple growth tips into a small defect in the epineurial collagen.

The platform also captured the slowest process of all: repair across a complete transection. The team cut the sciatic nerve entirely and bridged the 2.5-millimeter gap with a hemitubular PDMS conduit, chosen over a closed tube to permit optical access and nutrient exchange. Over days, mobile fluorescent cells, likely immune and stromal cells, populated the saline-filled gap, peaking in density around day eleven. By day 25, bundled axonal sprouts had crossed the conduit along its axis, and their density and organization continued to increase through day 35, accompanied by the return of grasping ability and sensation. Histology at day 59 confirmed small, myelinated regenerative axons at the distal end. In most of the conduit-repair mice followed, tissue cables formed, fluorescent regrowth appeared, and functional recovery was observed.

The authors are candid about limitations. Tissue scattering restricted imaging largely to the outermost portion of the nerve, an estimated 5 to 30 percent of its volume, and a fibrotic membrane inevitably formed against the implant within two to three weeks, degrading image quality, though it could often be mechanically cleared through the injection port. Whether that clearing itself disturbs regeneration remains untested, and the functional assessments in the uninjured window model involved small sample sizes. The transgenic reporters, too, are not perfectly cell-type-specific, labeling some non-neuronal and non-Schwann cell populations. Future refinements may include anti-fibrotic coatings, adaptive optics, three-photon excitation, and wearable or implantable cameras that could image awake, moving animals.

Even so, the implications are broad. By imaging the same nerve region repeatedly within the same animal, the technique eliminates inter-animal variability as a confound and makes it possible to link early injury events to later regenerative outcomes, something discrete histological sampling cannot do. On timescales of days to weeks, researchers can now track angiogenesis, Schwann cell migration, formation of the regenerative bands of Büngner, and extracellular matrix remodeling; on timescales of milliseconds to minutes, calcium transients, neuropeptide release, mitochondrial transport, and immune cell trafficking come within reach. The method is particularly suited to evaluating biofabricated nerve grafts, and could allow surgeons and scientists to see early whether a repair conduit is filling with regenerative tissue or failing. Combined in the future with genetically encoded calcium indicators or optogenetic actuators, the nerve window could enable both sensing and control of peripheral nerve activity, opening a new chapter in the study and treatment of peripheral nerve disorders.

Subject of Research: Longitudinal in vivo imaging of peripheral nerve injury and regeneration in mice using a soft PDMS optical window implant

Article Title: Longitudinal Single‐Axon‐Resolution Imaging of Peripheral Nerve Injury Response in Mice Using an Optical Window Implant

Article References: Luzhansky, I. D., Anisman, E., Perez, R., Zhang, S., Hoffman, M., Hunter, D., Cherian, A., Bonner, J., Feria, E., Ahmed, A., Malik, M., Du, J., Sudlow, L. C., Brogan, D. M., Wood, M. D., & Berezin, M. Y. (2026). Longitudinal Single‐Axon‐Resolution Imaging of Peripheral Nerve Injury Response in Mice Using an Optical Window Implant. Advanced Science, 13(53), Article e76375. https://doi.org/10.1002/advs.76375

Image Credits: AI Generated

DOI: 10.1002/advs.76375

Keywords: peripheral nerve injury, sciatic nerve, PDMS optical window, axon regeneration, Schwann cells, two-photon microscopy, Wallerian degeneration, growth cones, nerve conduit repair, endoneurial channels, intravital imaging, Thy1-YFP mice

The problem, the researchers argue, is a fundamental spatial paradox that has been largely overlooked in neural tissue engineering. On one side of the equation, engineers want to pack conduits with as much internal structure as possible—aligned fibers, hydrogels, or micro-grooved filaments that mimic the anisotropic architecture of native nerve fascicles and provide topographical cues to guide regenerating axons. On the other side, every cubic millimeter occupied by filler is a cubic millimeter unavailable for the biological work of repair. Over-densified conduits crowd out the regenerative lumen, restricting nutrient diffusion, impeding macrophages as they clear myelin debris, physically blocking endothelial cells trying to build new blood vessels, and ultimately forming a mechanical barrier against axonal extension. Under-filled conduits, conversely, cannot supply enough directional guidance or mechanical support to bridge the gap. Somewhere between these two failure modes lies a Goldilocks zone, and until now, no one had systematically mapped it.

Led by Xiushuai Shang, You Wu, Yifan Li, and colleagues working under the supervision of Deteng Zhang, Shude Yang, and Sanzhong Xu, the team engineered a hierarchical composite nerve guidance conduit designed to test that zone rigorously. The outer sheath was fabricated from poly(L-lactide-co-caprolactone), or PLCL, a biodegradable elastomeric polyester, using a sandwich hot-pressing method in which the polymer film was pressed at 180 degrees Celsius between micropatterned polydimethylsiloxane templates. The result was a film bearing anisotropic microgrooves with 20-micrometer ridges and 40-micrometer grooves, a geometry previously shown to promote the adhesion, proliferation, and migration of Schwann cells. Because PLCL is inherently hydrophobic, the films were treated with oxygen plasma and then coated with CQAASIKVAV, a laminin-derived peptide, to boost cellular affinity. Contact angle measurements confirmed that the microgrooves preferentially enhanced hydrophilicity along the groove direction, dropping from roughly 80 degrees on flat film to about 45 degrees parallel to the pattern, thanks to capillary action.

Inside this micropatterned sheath, the researchers placed double-sided micropatterned PLCL filaments, each about 200 micrometers thick, aligned parallel to the conduit’s longitudinal axis. A clever flat-to-tubular assembly technique locked the filaments in their parallel orientation: the film was laid flat, the filaments distributed evenly across its surface, and the whole construct then rolled and sutured into a tube, preventing the fillers from clumping to one side. The team then varied the volumetric filling ratio across six levels—0, 5, 10, 20, 30, and 50 percent—by implanting 0, 3, 6, 12, 18, or 30 filaments respectively into conduits of 0.05 cubic centimeters total volume. These devices were implanted into rats with 10-millimeter sciatic nerve transections, a demanding model of long-distance peripheral nerve repair, and evaluated over 12 weeks against an autologous nerve graft control.

The functional results were striking. Gait analysis at 12 weeks showed that rats receiving conduits filled at 5 percent walked with clear interdigital spaces and normal paw openings on the affected limb, closely matching the autograft group, while animals in the 0, 20, 30, and 50 percent groups showed toe gnawing and weakness. Electrophysiological testing revealed that nerve conduction velocities in the 5 and 10 percent groups were more than twice as fast as in the empty conduit group. The target muscle told the same story: the gastrocnemius muscles of rats with 5 and 10 percent fill showed the least atrophy, with tightly arranged, thick muscle fibers on histology, whereas severe atrophy and collagen deposition plagued the empty and heavily filled groups. In short, both extremes of the filling spectrum failed, and the therapeutic window sat squarely between them.

Histological and ultrastructural analysis of the regenerated nerves sharpened the picture. Toluidine blue staining and transmission electron microscopy showed that the 5 percent group produced the densest, most uniformly circular myelin sheaths, with the greatest myelin thickness and axon diameter, while the autograft and 10 percent groups performed comparably. Immunofluorescence for NF200, a marker of axonal integrity, and S100beta, a marker of Schwann cell support, confirmed robust nerve fiber regeneration in the optimally filled conduits. Perhaps most revealing was the vascular analysis: staining for the endothelial markers CD34 and CD31 showed that the 5 percent group had markedly higher vascular density than any other group, while fillings above 10 percent appeared to actively hinder blood vessel formation, leaving only sparse endothelial signal. Angiogenesis, the researchers note, is essential for delivering nutrients and oxygen to the metabolically demanding process of remyelination, so crowding out blood vessels is a direct route to regeneration failure.

To open the black box of how these physical architectures translate into cellular behavior, the team performed transcriptomic sequencing at multiple levels. In vitro, Schwann cells cultured on micropatterned films elongated dramatically, aligning parallel to the grooves with significantly increased aspect ratios and reduced orientation angles, and RNA sequencing revealed 219 upregulated and 152 downregulated genes relative to flat films. Bone marrow-derived macrophages showed an even more intriguing response: on micropatterned surfaces, the proportion of elongated, fusiform cells rose significantly, a morphology associated with the pro-regenerative M2 phenotype, and their transcriptomes were enriched in the PI3K-Akt signaling pathway, focal adhesion, axon guidance, and adherens junction pathways. In vivo, comparing regenerated nerves from empty versus 5 percent filled conduits yielded 13,541 differentially expressed genes, with the top enriched pathways including cytoskeletal organization, focal adhesion, PI3K-Akt signaling, extracellular matrix-receptor interaction, and axon guidance. A three-way comparison across the Schwann cell, macrophage, and regenerated nerve datasets converged on a small set of shared genes, chief among them Ccn1, also known as Cyr61.

Ccn1 is a mechanosensitive, secreted matricellular protein that interacts with integrin receptors to modulate cell adhesion, migration, proliferation, and differentiation. Prior work has shown that Cyr61 promotes Schwann cell proliferation and migration via the alphavbeta3 integrin, regulates c-Jun expression, and supports motor neuron growth, thereby facilitating axonal regeneration. Its emergence as a central node in this study suggests that the engineered 3D microenvironment exerts its effects partly through mechanotransduction pathways that funnel physical cues from focal adhesions into cytoskeletal rearrangement and extracellular matrix remodeling. In effect, the conduit’s geometry is not merely passive scaffolding; it is an active signaling environment that orchestrates Schwann cell alignment into artificial Bands of Büngner, biases macrophages toward a pro-resolving state, and leaves just enough open space for blood vessels to invade and support remyelination.

The authors are candid about the study’s limitations. The 12-week observation window captures only the early stage of PLCL degradation, and the acidic byproducts released during prolonged polymer breakdown could shift macrophage polarization toward a pro-inflammatory phenotype and affect long-term matrix stability. The work was also conducted exclusively in rodents, and validation in large animal models such as canines or non-human primates will be essential before clinical translation. Functional validation with pathway inhibitors was not performed, leaving the mechanistic claims correlational. Nonetheless, the central achievement stands: by systematically sweeping filling ratios from 0 to 50 percent, the team established that 5 to 10 percent volumetric occupation represents the optimal structural threshold, delivering electrophysiological recovery, remyelination, and muscle preservation essentially comparable to autologous nerve grafts.

Beyond the immediate promise for peripheral nerve repair, the study articulates a broader and potentially transformative principle: that the spatial density of intraluminal architecture is a first-order design variable in tissue engineering, every bit as important as material chemistry or surface topography. The same spatial paradox—maximizing guidance signals while preserving room for multicellular infiltration, angiogenesis, and immune resolution—almost certainly governs the performance of scaffolds for spinal cord, muscle, and other vascularized tissues. By quantifying the Goldilocks zone rather than assuming that more structure is always better, this work offers a translatable paradigm for the rational, biomechanically optimized design of next-generation regenerative implants.

Subject of Research: Optimized spatial density of micropatterned PLCL filaments in nerve guidance conduits for peripheral nerve regeneration

Article Title: Balancing topographical guidance and spatial capacity: Optimized spatial density of micropatterned filaments for enhanced peripheral nerve regeneration

Article References: Shang, X., Wu, Y., Li, Y., Li, J., Jiang, S., Shen, M., Chen, J., Zhang, D., Yang, S., & Xu, S. (2026). Balancing topographical guidance and spatial capacity: Optimized spatial density of micropatterned filaments for enhanced peripheral nerve regeneration. Materials Today Bio, 41, Article 103670. https://doi.org/10.1016/j.mtbio.2026.103670

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103670

Keywords: peripheral nerve injury, nerve guidance conduit, PLCL, micropatterned filaments, Schwann cells, macrophage polarization, angiogenesis, remyelination, PI3K-Akt signaling, Ccn1, tissue engineering, transcriptomics